Skip to content

Study · In vitro (cells) · 1982

2 results

Interleukin-2 and serum thymic factor enable autologous rosette-forming T lymphocytes to generate helper and cytotoxic functions.

Sugawara I, Palacios R

Scandinavian journal of immunology1 Feb 1982Cited by 8 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Mechanism

    In human Tar lymphocytes, serum thymic factor enabled cytotoxicity against allogeneic targets, whereas cells without either stimulant showed little or no cytotoxicity.

    In plain wordsIn human cells, FTS enabled killing of allogeneic target cells compared with little or no activity without either stimulant.

    Outcome
    IncreaseCytotoxicity against allogeneic target cells
    Study

    humann: not reported in source

    Autologous rosette-forming T lymphocytes
    Comparator
    Absence of interleukin-2 or serum thymic factor
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In addition, we found that Tar lymphocytes were able to develop cytotoxicity against allogeneic and trinitrophenol (TNP)-conjugated autologous target cells in the presence of interleukin-2 (IL-2) or serum thymic factor.
    2 context sentences
    Summary · context
    However, these cells showed little or nor cytotoxicity in the absence of interleukin-2 or serum thymic factor.
    Summary · context
    The autologous rosette-forming T cells (Tar cells) isolated by means of their ability to form rosettes with autologous erythrocytes were characterized by the use of OKT monoclonal anti-human T-cell subset antibodies and a monoclonal anti-HLA-DR antibody.
  2. 02LabIn vitro (cells)Mechanism

    In human Tar lymphocytes, serum thymic factor enabled cytotoxicity against TNP-conjugated autologous targets, whereas cells without either stimulant showed little or no cytotoxicity.

    In plain wordsIn human cells, FTS enabled killing of TNP-conjugated autologous targets compared with little or no activity without either stimulant.

    Outcome
    IncreaseCytotoxicity against TNP-conjugated autologous target cells
    Study

    humann: not reported in source

    Autologous rosette-forming T lymphocytes
    Comparator
    Absence of interleukin-2 or serum thymic factor
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In addition, we found that Tar lymphocytes were able to develop cytotoxicity against allogeneic and trinitrophenol (TNP)-conjugated autologous target cells in the presence of interleukin-2 (IL-2) or serum thymic factor.
    2 context sentences
    Summary · context
    However, these cells showed little or nor cytotoxicity in the absence of interleukin-2 or serum thymic factor.
    Summary · context
    The autologous rosette-forming T cells (Tar cells) isolated by means of their ability to form rosettes with autologous erythrocytes were characterized by the use of OKT monoclonal anti-human T-cell subset antibodies and a monoclonal anti-HLA-DR antibody.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.